(S1 (S (S (VP (VBG Targeting) (NP (NN TNF)) (PP (IN for) (NP (NP (NN Treatment)) (PP (IN of) (NP (NP (NN Cancer)) (CC and) (NP (NN Autoimmunity)))))))) (. .)))
(S1 (S (S (NP (NP (NN Tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB first)) (VP (VBN isolated) (ADVP (NP (CD two) (NNS decades)) (RB ago)) (PP (IN as) (NP (NP (DT a) (JJ macrophageproduced) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (ADVP (RB effectively)) (VP (VB kill) (NP (NN tumor) (NNS cells))))))))))) (. .)))
(S1 (S (S (NP (NN TNF-alpha)) (VP (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT an) (JJ essential) (NN component)) (PP (IN of) (NP (DT the) (JJ immune) (NN system))))) (CC and) (VP (VBZ is) (VP (VBN required) (PP (PP (IN for) (NP (NN hematopoiesis))) (, ,) (PP (IN for) (NP (NP (NN protection)) (PP (IN from) (NP (JJ bacterial) (NN infection))))) (CC and) (PP (IN for) (NP (JJ immune) (JJ cell-mediated) (NN cytotoxicity)))))))) (. .)))
(S1 (S (S (NP (JJ Extensive) (NN research)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ has) (VP (VBN revealed) (SBAR (IN that) (S (NP (NN TNF-alpha)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ major) (NNS players)) (PP (IN in) (NP (NP (NN tumor) (NN initiation)) (, ,) (NP (NN proliferation)) (, ,) (NP (NN invasion)) (, ,) (NP (NN angiogenesis)) (CC and) (NP (NN metastasis))))))))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ proinflammatory) (NNS activities)) (VP (VBP link) (NP (NN TNF-alpha)) (PP (IN with) (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NP (JJ autoimmune) (NNS diseases)) (, ,) (PP (VBG including) (NP (NP (NN psoriasis)) (, ,) (NP (JJ inflammatory) (NN bowel) (NN disease)) (, ,) (NP (JJ rheumatoid) (NN arthritis)) (, ,) (NP (JJ systemic) (NN sclerosis)) (, ,) (NP (JJ systemic) (NN lupus) (NN erythematosus)) (, ,) (NP (JJ multiple) (NN sclerosis)) (, ,) (NP (NN diabetes)) (CC and) (NP (JJ ankylosing) (NN spondylitis)))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Systemic) (NNS inhibitors)) (PP (IN of) (NP (NN TNF))) (PP (JJ such) (IN as) (NP (NP (NP (NP (NN etanercept)) (PRN (-LRB- -LRB-) (NP (NNP Enbrel)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (DT a) (JJ soluble) (NN TNF) (NN receptor)) (-RRB- -RRB-))) (CC and) (NP (NP (NN infliximab)) (PRN (-LRB- -LRB-) (NP (NN Remicade)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN adalimumab)) (PRN (-LRB- -LRB-) (NP (NNP Humira)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (JJ anti-TNF) (NNS antibodies)) (-RRB- -RRB-)))))) (VP (VBP have) (VP (VBN been) (ADJP (JJ approved) (PP (IN for) (NP (NP (DT the) (NN treatment) (JJ inflammatory) (NN bowel) (NN disease)) (, ,) (NP (NP (NN psoriasis)) (CC and) (NP (JJ rheumatoid) (NN arthritis))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS drugs)) (, ,) (ADVP (RB however)) (, ,) (VP (VP (VBP exhibit) (NP (JJ severe) (JJ side) (NNS effects))) (CC and) (VP (VBP are) (ADJP (JJ expensive))))) (. .)))
(S1 (S (S (NP (NP (ADJP (RB Hence) (RB orally) (JJ active)) (NNS blockers)) (PP (IN of) (NP (NN TNF-alpha))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (ADJP (JJ safe)) (, ,) (ADJP (JJ efficacious)) (CC and) (ADJP (JJ inexpensive))))))) (VP (VBP are) (ADVP (RB urgently)) (VP (VBN needed)))) (. .)))
(S1 (S (S (S (NP (NP (JJ Numerous) (NNS products)) (PP (IN from) (NP (NP (NN fruits)) (, ,) (NP (NN vegetable)) (CC and) (NP (JJ traditional) (JJ medicinal) (NNS plants))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB suppress) (NP (NP (NN TNF) (NN expression)) (CC and) (NP (NN TNF) (NN signaling))))))))))) (CC but) (S (NP (PRP$ their) (JJ clinical) (NN potential)) (VP (VBZ is) (ADVP (RB yet)) (ADJP (JJ uncertain))))) (. .)))
